Xiu-ling Deng

76 West Yanta Road
Xi'an, 710061, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 46 publications

Expression, Localization and Actions of Galectin-3: Implications in the Pathophysiology and Therapy of Cardiovascular Disease.

Expression, Localization and Actions of Galectin-3: Implications in the Pathophysiology and Therapy of Cardiovascular Disease.

Journal: International journal of molecular sciences

Published: May 12, 2026

Dimethyl Fumarate Reverses β-Adrenoceptor-Mediated Myocardial Fibrosis in Mice by Inhibiting Yes-Associated Protein-Regulated Expression of Intermediate-Conductance Ca2+-Activated K+ Channel in Fibroblasts.

Dimethyl Fumarate Reverses β-Adrenoceptor-Mediated Myocardial Fibrosis in Mice by Inhibiting Yes-Associated Protein-Regulated Expression of Intermediate-Conductance Ca2+-Activated K+ Channel in Fibroblasts.

Journal: Journal of the American Heart Association

Published: March 18, 2026

Corrigendum to "Angiotensin II upregulates KCa3.1 channels and stimulates cell proliferation in rat cardiac fibroblasts". [Biochem. Pharmacol. 85 (2013) 1486-1494].

Corrigendum to "Angiotensin II upregulates KCa3.1 channels and stimulates cell proliferation in rat cardiac fibroblasts". [Biochem. Pharmacol. 85 (2013) 1486-1494].

Journal: Biochemical pharmacology

Published: February 14, 2026

S1PR1-MYPT1 Maintains Coronary Endothelial Barrier in Pressure-Overloaded Hearts.

S1PR1-MYPT1 Maintains Coronary Endothelial Barrier in Pressure-Overloaded Hearts.

Journal: Hypertension (Dallas, Tex. : 1979)

Published: November 21, 2025

Galectin-3 gene deletion alters lipid profile in healthy and cardiomyopathy mouse hearts.

Galectin-3 gene deletion alters lipid profile in healthy and cardiomyopathy mouse hearts.

Journal: Biochimica et biophysica acta. Molecular and cell biology of lipids

Published: February 19, 2025

Hippo pathway activation mediates cardiomyocyte ferroptosis to promote dilated cardiomyopathy through downregulating NFS1.

Hippo pathway activation mediates cardiomyocyte ferroptosis to promote dilated cardiomyopathy through downregulating NFS1.

Journal: Redox biology

Published: February 02, 2025

Upregulating vascular endothelial KCa2.3 channels alleviates pulmonary hypertension in mice.

Upregulating vascular endothelial KCa2.3 channels alleviates pulmonary hypertension in mice.

Journal: Molecular pharmacology

Published: December 20, 2024

KCa3.1 upregulation mediated by Ang II-induced JNK/AP-1 activation contributes to atrial fibrosis.

KCa3.1 upregulation mediated by Ang II-induced JNK/AP-1 activation contributes to atrial fibrosis.

Journal: Cellular signalling

Published: November 29, 2024

Elevated KCa3.1 expression by angiotensin II via the ERK/NF-κB pathway contributes to atrial fibrosis.

Elevated KCa3.1 expression by angiotensin II via the ERK/NF-κB pathway contributes to atrial fibrosis.

Journal: Journal of molecular and cellular cardiology

Published: August 11, 2024

Glutaminolysis and α-ketoglutarate-stimulated KCa3.1 expression contribute to β-adrenoceptor activation-induced myocardial fibrosis in mice.

Glutaminolysis and α-ketoglutarate-stimulated KCa3.1 expression contribute to β-adrenoceptor activation-induced myocardial fibrosis in mice.

Journal: Science China. Life sciences

Published: July 31, 2024

AMPK phosphorylation of KCa2.3 alleviates angiotensin II-induced endothelial dysfunction.

AMPK phosphorylation of KCa2.3 alleviates angiotensin II-induced endothelial dysfunction.

Journal: Biochemical pharmacology

Published: July 24, 2024

Hippo pathway activation causes multiple lipid derangements in a murine model of cardiomyopathy.

Hippo pathway activation causes multiple lipid derangements in a murine model of cardiomyopathy.

Journal: Biochimica et biophysica acta. Molecular and cell biology of lipids

Published: July 19, 2024

Showing 1-12 of 46

Last Updated: 09/26/2026